Trilogy Capital’s Corpay CPAY Stock Holding History

Trilogy Capital’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15	Closed	-$3K	–	587
2018 Q3	$3K	Hold	15	–	–	﹤0.01%	472
2018 Q2	$3K	Buy	+15	New	+$3.08K	﹤0.01%	431

Other funds holding CPAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Trilogy Capital's CPAY Position: Q4 2018 in Review

Trilogy Capital sold out of Corpay (CPAY) in Q4 2018, closing a stake of 15 shares — an estimated $3K sold.

Trilogy Capital first reported a position in CPAY in Q2 2018 and held it in 2 quarters. The position peaked at $3K in Q3 2018. 461 funds tracked by Wall St. Rank hold CPAY as of Q4 2018.

Trilogy Capital reported no remaining Corpay position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 15 Corpay shares in Q4 2018, an estimated $3K.
Trilogy Capital first reported a position in Corpay in Q2 2018 and held it in 2 quarters.
Trilogy Capital's Corpay position peaked at $3K in Q3 2018.
461 funds tracked by Wall St. Rank held Corpay as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.